Although no studies have directly investigated RSAD2 in the treatment of HPV-related diseases, existing research suggests that RSAD2 influences viral replication and infection persistence in other viral infections, such as HIV and measles virus [59, 60], providing insights into its potential therapeutic applications in HPV-related diseases. Here, RSAD2 is linked to viral infectious disease.